Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, November 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
First SYGNIS QualiPhi®-based Products Launched by QIAGEN
Thursday, February 13, 2014
QualiPhi®, now renamed SensiPhi®, targets sophisticated applications for DNA amplification.

QIAGEN to Launch Innovative Next-generation Sequencing (NGS) Products
Thursday, February 13, 2014
The solutions will enable NGS users to generate more valuable insights from any sample.

Rubicon Launches PicoPLEX™ DNA-seq for Illumina NGS Platforms
Tuesday, February 11, 2014
PicoPLEX™ single-cell library preparation kits for IVF and other applications now available for sequencing on Illumina platforms.

Protect Pipette After Over Pipetting with Eppendorf
Wednesday, February 05, 2014
New ep Dualfilter T.I.P.S® SealMax filter tips from Eppendorf.

Illumina Unveils Strategic Roadmap for Market Expansion
Saturday, February 01, 2014
Company positions for growth in key genomics segments, introduces new workflow solutions at investor day.

Roche Announces the Launch of SeqCap Epi Target Enrichment System
Saturday, February 01, 2014
Novel NGS target enrichment solution for methylation assessment.

At BiOS SCHOTT to Present a Variety of Glass Substrates for Use in Biotechnology
Friday, January 31, 2014
Specialty glass and in-house micro-structuring technology for top quality substrates.

Maverix, $100,000 Order from University of Missouri For 99 Lives Cat Whole Genome Sequencing Initiative
Wednesday, January 29, 2014
Maverix Analytic Platform to be Used for Analysis and Hosting of Community of Discovery.

Sapio Sciences Announces Exemplar NGS LIMS for Next Gen Sequencing Labs
Monday, January 27, 2014
Exemplar NGS provides pre-built, clinical standard workflows for leading NGS platforms

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 219
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv